נפח מכירות החברה Notable Labs (NTBL)

Notable Labs, Ltd. (NTBL) is developing an IT solution for therapy selection while facing challenges related to clinical validation and partnership costs. Revenue is based on precision diagnostics of patient drug responses. The current pre-revenue stage and linear growth of expenses are hindering scalability. The company's commercial sales metric has reached 0.00, as clearly demonstrated by this chart.

The retention of unique AI specialists and biologists at Notable Labs, Ltd. (NTBL) converts directly into the commercial value of developed therapies. This metric aggregates the total cash flow from service delivery, reflecting the efficiency of intellectual capital monetization through the volume of market transactions. An analysis of the company's sales profile allows for an assessment of the balance between operational income stability and the asset's capitalization growth potential.